# CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

> **NCT06034535** · PHASE2 · RECRUITING · sponsor: **Hong Kong Children's Hospital** · enrollment: 23 (estimated)

## Conditions studied

- Hematopoietic Organs; Disorder

## Interventions

- **BIOLOGICAL:** CD62L depleted donor lymphocyte infusion

## Key facts

- **NCT ID:** NCT06034535
- **Lead sponsor:** Hong Kong Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2025-09
- **Final completion:** 2026-09
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06034535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06034535, "CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06034535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*